Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®)
Public ClinicalTrials.gov record NCT02474407. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Randomized, Crossover Pharmacokinetic Study to Determine the Bioavailability, Safety and Tolerability of Single Doses of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®) in Patients With Refractory Epilepsy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multi-center, open-label, crossover, pharmacokinetic, bio-availability study involving adolescents and adults with refractory (drug-resistant) epilepsy. Cohort 1 comprises the subjects used to determine the relative bioavailability of DZNS versus DRG (Diastat)
Study identification
- NCT ID
- NCT02474407
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 78 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2015 (Type not available)
- Primary completion
- May 2016 (Actual)
- Completion
- Jul 2016 (Actual)
- Last update posted
- Oct 16, 2018
2015 – 2016
United States locations
- U.S. sites
- 22
- U.S. states
- 16
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Acorda Site #115 | Little Rock | Arkansas | 72205 | — |
| Acorda Site #127 | Washington D.C. | District of Columbia | 20010 | — |
| Acorda Site #101 | Tampa | Florida | 33606 | — |
| Acorda Site #125 | Honolulu | Hawaii | 96817 | — |
| Acorda Site #104 | Lexington | Kentucky | 40513 | — |
| Acorda Site #111 | Baltimore | Maryland | 21201 | — |
| Acorda Site #102 | Bethesda | Maryland | 20817 | — |
| Acorda Site #110 | Ann Arbor | Michigan | 48105 | — |
| Acorda Site #117 | Jackson | Mississippi | 39216 | — |
| Acorda Site #112 | St Louis | Missouri | 63131 | — |
| Acorda Site #128 | Edison | New Jersey | 08818 | — |
| Acorda Site #121 | Hackensack | New Jersey | 07601 | — |
| Acorda Site #123 | Amherst | New York | 14226 | — |
| Acorda Site #119 | Rochester | New York | 14642 | — |
| Acorda Site #132 | Chapel Hill | North Carolina | 27599 | — |
| Acorda Site #114 | Portland | Oregon | 97239 | — |
| Acorda Site #116 | Philadelphia | Pennsylvania | 19104 | — |
| Acorda Site #105 | Philadelphia | Pennsylvania | 19107 | — |
| Acorda Site #130 | Memphis | Tennessee | 38105 | — |
| Acorda Site #103 | Bellaire | Texas | 77401 | — |
| Acorda Site #122 | Dallas | Texas | 75251 | — |
| Acorda Site #108 | Houston | Texas | 77004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02474407, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 16, 2018 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02474407 live on ClinicalTrials.gov.